Suppr超能文献

三结构域蛋白 24(Trim24/Tif1α)肿瘤抑制蛋白是干扰素(IFN)/信号转导和转录激活因子(STAT)信号通路的新型负调节剂,通过抑制视黄酸受体 α(Rarα)发挥作用。

Tripartite motif 24 (Trim24/Tif1α) tumor suppressor protein is a novel negative regulator of interferon (IFN)/signal transducers and activators of transcription (STAT) signaling pathway acting through retinoic acid receptor α (Rarα) inhibition.

机构信息

Department of Functional Genomics, Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/Université Louis Pasteur, BP 10142, 67404 Illkirch-Cedex, Communauté Urbaine de Strasbourg, France.

出版信息

J Biol Chem. 2011 Sep 23;286(38):33369-79. doi: 10.1074/jbc.M111.225680. Epub 2011 Jul 18.

Abstract

Recent genetic studies in mice have established that the nuclear receptor coregulator Trim24/Tif1α suppresses hepatocarcinogenesis by inhibiting retinoic acid receptor α (Rara)-dependent transcription and cell proliferation. However, Rara targets regulated by Trim24 remain unknown. We report that the loss of Trim24 resulted in interferon (IFN)/STAT pathway overactivation soon after birth (week 5). Despite a transient attenuation of this pathway by the induction of several IFN/STAT pathway repressors later in the disease, this phenomenon became more pronounced in tumors. Remarkably, Rara haplodeficiency, which suppresses tumorigenesis in Trim24(-/-) mice, prevented IFN/STAT overactivation. Moreover, together with Rara, Trim24 bound to the retinoic acid-responsive element of the Stat1 promoter and repressed its retinoic acid-induced transcription. Altogether, these results identify Trim24 as a novel negative regulator of the IFN/STAT pathway and suggest that this repression through Rara inhibition may prevent liver cancer.

摘要

最近在小鼠中的遗传研究已经确立,核受体辅激活因子 Trim24/Tif1α 通过抑制视黄酸受体 α(Rara)依赖性转录和细胞增殖来抑制肝癌发生。然而,Trim24 调节的 Rara 靶标仍然未知。我们报告说,Trim24 的缺失导致出生后不久(第 5 周)干扰素(IFN)/STAT 途径过度激活。尽管在疾病后期通过诱导几种 IFN/STAT 途径抑制剂来短暂减弱该途径,但在肿瘤中这种现象变得更加明显。值得注意的是,抑制 Trim24(-/-) 小鼠肿瘤发生的 Rara 单倍体缺失阻止了 IFN/STAT 的过度激活。此外,Trim24 与 Rara 一起结合到 Stat1 启动子的视黄酸反应元件上,并抑制其视黄酸诱导的转录。总之,这些结果表明 Trim24 是 IFN/STAT 途径的一种新型负调节剂,并提示通过抑制 Rara 来抑制可能防止肝癌。

相似文献

2
Loss of Trim24 (Tif1alpha) gene function confers oncogenic activity to retinoic acid receptor alpha.
Nat Genet. 2007 Dec;39(12):1500-6. doi: 10.1038/ng.2007.15. Epub 2007 Nov 18.
3
Trim24 (Tif1 alpha): an essential 'brake' for retinoic acid-induced transcription to prevent liver cancer.
Cell Cycle. 2008 Dec;7(23):3647-52. doi: 10.4161/cc.7.23.7123. Epub 2008 Dec 5.
4
Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinoma.
Proc Natl Acad Sci U S A. 2011 May 17;108(20):8212-7. doi: 10.1073/pnas.1101544108. Epub 2011 Apr 29.
6
Trim24-repressed VL30 retrotransposons regulate gene expression by producing noncoding RNA.
Nat Struct Mol Biol. 2013 Mar;20(3):339-46. doi: 10.1038/nsmb.2496. Epub 2013 Feb 3.
9
TRIM24 mediates the interaction of the retinoic acid receptor alpha with the proteasome.
FEBS Lett. 2018 Apr;592(8):1426-1433. doi: 10.1002/1873-3468.13033. Epub 2018 Mar 30.
10
Biological functional annotation of retinoic acid alpha and beta in mouse liver based on genome-wide binding.
Am J Physiol Gastrointest Liver Physiol. 2014 Jul 15;307(2):G205-18. doi: 10.1152/ajpgi.00105.2014. Epub 2014 May 15.

引用本文的文献

1
TRIM24 regulates chromatin remodeling and calcium dynamics in cardiomyocytes.
Cell Commun Signal. 2025 Jul 1;23(1):312. doi: 10.1186/s12964-025-02323-8.
3
The tripartite motif-containing 24 is a multifunctional player in human cancer.
Cell Biosci. 2024 Aug 19;14(1):103. doi: 10.1186/s13578-024-01289-3.
4
Regulation of Mitochondria-Derived Immune Activation by 'Antiviral' TRIM Proteins.
Viruses. 2024 Jul 19;16(7):1161. doi: 10.3390/v16071161.
5
Transcriptional co-activators: emerging roles in signaling pathways and potential therapeutic targets for diseases.
Signal Transduct Target Ther. 2023 Nov 13;8(1):427. doi: 10.1038/s41392-023-01651-w.
6
Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex.
Cell Oncol (Dordr). 2023 Dec;46(6):1763-1775. doi: 10.1007/s13402-023-00843-4. Epub 2023 Jul 19.
7
Myc promotes polyploidy in murine trophoblast cells and suppresses senescence.
Development. 2023 Jun 1;150(11). doi: 10.1242/dev.201581. Epub 2023 Jun 6.
8
TRIM24 controls induction of latent HIV-1 by stimulating transcriptional elongation.
Commun Biol. 2023 Jan 23;6(1):86. doi: 10.1038/s42003-023-04484-z.
9
Inhibition of the TRIM24 bromodomain reactivates latent HIV-1.
Sci Rep. 2023 Jan 11;13(1):556. doi: 10.1038/s41598-023-27765-3.
10
The roles and targeting options of TRIM family proteins in tumor.
Front Pharmacol. 2022 Sep 30;13:999380. doi: 10.3389/fphar.2022.999380. eCollection 2022.

本文引用的文献

1
The ISG15/USP18 ubiquitin-like pathway (ISGylation system) in hepatitis C virus infection and resistance to interferon therapy.
Int J Biochem Cell Biol. 2011 Oct;43(10):1427-31. doi: 10.1016/j.biocel.2011.06.006. Epub 2011 Jun 16.
2
Usp18 regulates epidermal growth factor (EGF) receptor expression and cancer cell survival via microRNA-7.
J Biol Chem. 2011 Jul 15;286(28):25377-86. doi: 10.1074/jbc.M111.222760. Epub 2011 May 18.
3
Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinoma.
Proc Natl Acad Sci U S A. 2011 May 17;108(20):8212-7. doi: 10.1073/pnas.1101544108. Epub 2011 Apr 29.
4
TRIM24 links a non-canonical histone signature to breast cancer.
Nature. 2010 Dec 16;468(7326):927-32. doi: 10.1038/nature09542.
6
Molecularly targeted therapy in hepatocellular carcinoma.
Biochem Pharmacol. 2010 Sep 1;80(5):550-60. doi: 10.1016/j.bcp.2010.03.034. Epub 2010 Apr 4.
7
Immunity, inflammation, and cancer.
Cell. 2010 Mar 19;140(6):883-99. doi: 10.1016/j.cell.2010.01.025.
8
Identification of USP18 as an important regulator of the susceptibility to IFN-alpha and drug-induced apoptosis.
Cancer Res. 2010 Jan 15;70(2):655-65. doi: 10.1158/0008-5472.CAN-09-1942. Epub 2010 Jan 12.
9
10
STAT1 pathway mediates amplification of metastatic potential and resistance to therapy.
PLoS One. 2009 Jun 8;4(6):e5821. doi: 10.1371/journal.pone.0005821.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验